1
|
Shuman HL, Grupp AM, Robb LA, Akers KG, Bedi G, Shah MA, Janis A, Caldart CG, Gupta U, Vaghasia JK, Panneerselvam A, Kazeem AO, Amutah-Onukagha NN, Levine DL. Approaches and geographical locations of respectful maternity care research: A scoping review. PLoS One 2023; 18:e0290434. [PMID: 37616299 PMCID: PMC10449213 DOI: 10.1371/journal.pone.0290434] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2021] [Accepted: 08/08/2023] [Indexed: 08/26/2023] Open
Abstract
BACKGROUND Peripartum mistreatment of women contributes to maternal mortality across the globe and disproportionately affects vulnerable populations. While traditionally recognized in low/low-middle-income countries, the extent of research on respectful maternity care and the types of mistreatment occurring in high-income countries is not well understood. We conducted a scoping review to 1) map existing respectful maternity care research by location, country income level, and approach, 2) determine if high-income countries have been studied equally when compared to low/low-middle-income countries, and 3) analyze the types of disrespectful care found in high-income countries. METHODS A systematic search for published literature up to April 2021 using PubMed/MEDLINE, EMBASE, CINAHL Complete, and the Maternity & Infant Care Database was performed. Studies were included if they were full-length journal articles, published in any language, reporting original data on disrespectful maternal care received from healthcare providers during childbirth. Study location, country income level, types of mistreatment reported, and treatment interventions were extracted. This study was registered on PROSPERO, number CRD42021255337. RESULTS A total of 346 included studies were categorized by research approach, including direct labor observation, surveys, interviews, and focus groups. Interviews and surveys were the most common research approaches utilized (47% and 29% of all articles, respectively). Only 61 (17.6%) of these studies were conducted in high-income countries. The most common forms of mistreatment reported in high-income countries were lack of informed consent, emotional mistreatment, and stigma/discrimination. CONCLUSIONS Mapping existing research on respectful maternity care by location and country income level reveals limited research in high-income countries and identifies a need for a more global approach. Furthermore, studies of respectful maternity care in high-income countries identify the occurrence of all forms of mistreatment, clashing with biases that suggest respectful maternity care is only an issue in low-income countries and calling for additional research to identify interventions that embrace an equitable, patient-centric empowerment model of maternity care.
Collapse
Affiliation(s)
- Hannah L. Shuman
- Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, United States of America
| | - Annika M. Grupp
- Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, United States of America
| | - Lauren A. Robb
- Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, United States of America
| | - Katherine G. Akers
- Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, United States of America
| | - Gurbani Bedi
- Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, United States of America
| | - Miloni A. Shah
- Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, United States of America
| | - Andrea Janis
- Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, United States of America
| | - Caroline G. Caldart
- Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, United States of America
| | - Urvashi Gupta
- Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, United States of America
| | - Janki K. Vaghasia
- Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, United States of America
| | - Aishwarya Panneerselvam
- Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, United States of America
| | - Aisha O. Kazeem
- Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, United States of America
| | - Ndidiamaka N. Amutah-Onukagha
- Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan, United States of America
| | - Diane L. Levine
- Department of Public Health and Community Medicine, Tufts University, Boston, Massachusetts, United States of America
| |
Collapse
|
2
|
Manimekalai D, Senthilkumar G, Ambikapathy V, Panneerselvam A. Efficacy of Aspergillus sp in the Production of Protease Enzyme with Different Substrates. JPRI 2021. [DOI: 10.9734/jpri/2021/v33i60a34528] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
In the present study, the soil samples were collected from marine environment of Arichalmunai, Dhanushkodi, Ramnad District, Tamilnadu ,India. Fungal species were isolated by plating method, in 50% sea water containing potato dextrose agar medium .Totally 16 fungal species were isolated and identified from the soil sample. The production of protease from Aspergillus niger , A.flavus and A. terreus by liquid state fermentation. The production of protease enzyme was optimized by using fermentation medium containing different substrates. The maximum protease production was observed on wheat bran, containing medium. The protease production was maximum in temperature 35ºC were recorded. Wheat bran produced the maximum level protease. The optimization work also carried out. This study revealed that coastal environment provides impressive density of fungi in the East Coast of India and are unexplored for microbial resources can be useful in industry.
Collapse
|
3
|
Saboo B, Agarwal S, Gupta S, Makkar B, Panneerselvam A, Sahoo AK, Ramchandani GD, Das S, Erande S, Kadam Y, Abhyankar MV, Revankar S. REAL-world evidence of risk factors and comorbidities in YOUNG Indian adults with type 2 diabetes mellitus: A REAL YOUNG (diabetes) study. J Family Med Prim Care 2021; 10:3444-3452. [PMID: 34760771 PMCID: PMC8565132 DOI: 10.4103/jfmpc.jfmpc_2010_20] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2020] [Accepted: 03/01/2021] [Indexed: 11/04/2022] Open
Abstract
Objective To assess the clinical characteristics, risk factors, and comorbidities associated with type 2 diabetes mellitus (T2DM) in young adult patients. Methods This is a retrospective, multicentric real-world study that included young adults (18-45 years) with T2DM. Primary information including demographics, medical and family history, biochemical measures (pre-and post-prandial blood glucose levels, glycosylated hemoglobin [HbA1c] and blood pressure, and lipid parameters) smoking and drinking habits were collected retrospectively from the medical records of the respective hospitals/clinics. Data were analyzed using descriptive and appropriate comparative statistics. Results A total of 22,921 patients from 623 sites were included. The median age was 37.0 years and the majority were men (61.6%). The proportion of patients from the age group >35-≤45 years was 62.7%. Among all patients, 46.9% had only T2DM; however, 53.1% of patients had T2DM with other comorbidities (T2DM with hypertension, dyslipidemia, and both). The majority of patients had elevated body mass index (BMI) (overweight, 46.6%; and obese, 22.9%). Family history of T2DM (68.1%) was most common in overall population. Sedentary lifestyle (63.1%), alcohol consumption (38.9%), and regular smoking (23.1%) were the most common associations in patients with T2DM with dyslipidemia and hypertension. Uncontrolled HbA1c level (≥7%) were observed in 79.2% of patients. The level of HbA1c was significantly increased with the duration of T2DM and sedentary lifestyle (p < 0.001). Conclusion Higher BMI, family history of T2DM, sedentary lifestyle, alcohol consumption, and smoking were the most common risk facors, while hypertension and dyslipidemia were the most prevalent comorbidities associated with T2DM in young Indian adults.
Collapse
Affiliation(s)
- Banshi Saboo
- Department of Diabetology, Diabetes Care and Hormone Clinic, Ambawadi, Ahmedabad, Gujarat, India
| | - Sanjay Agarwal
- Department of Internal Medicine, Dr. Sanjay Agarwal's Aegle Clinic, City, Pune, Maharashtra, India
| | - Sunil Gupta
- Department of Diabetology, Sunil's Diabetes Care Research Centre, Nagpur, Maharashtra, India
| | - Brij Makkar
- Department of Diabetology, Dr. Makkar's Diabetes and Obesity Centre, Delhi, India
| | - A Panneerselvam
- Department of Diabetology, Aruna Diabetes Centre, Chennai, Tamil Nadu, India
| | - Abhay Kumar Sahoo
- Department of Endocrinology, IMS and SUM Hospital, Bhubaneshwar, Odisha, India
| | - G D Ramchandani
- Ramachandani Diabetes Care and Research Centre, Kota, Rajasthan, India
| | - Sambit Das
- Department of Endocrinology, Endeavour Clinics, Bhubaneswar, Odisha, India
| | - Suhas Erande
- Department of Diabetology, Akshay Hospital and Diabetic Speciality Centre and Insulin Pump Centre, Pune, Maharashtra, India
| | - Yogesh Kadam
- Department of Diabetology, Poona Diabetes Centre, Pune, Maharashtra, India
| | - Mahesh V Abhyankar
- Department of Scientific Services, Scientific Services, USV Private Limited, Mumbai, Maharashtra, India
| | - Santosh Revankar
- Department of Scientific Services, Scientific Services, USV Private Limited, Mumbai, Maharashtra, India
| |
Collapse
|
4
|
Shanmugapriya R, Rani ASS, Babu S, Ambikapathy V, Sengottain N, Panneerselvam A. Evaluation of Antibiotic Sensitivity Test against Ophthalmic Pathogens. JPRI 2021. [DOI: 10.9734/jpri/2021/v33i45a32755] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Ophthalmic infections can cause damage to the structure of the eye which can lead to vision loss and blindness if left untreated. Ophthalmic infection or eye infections are caused by exposure to bacterial, fungal viral and protozoan are common with frequently reported in Asian countries. In the present study, the external ocular infected samples collected from Thanjavur Medical College Hospital, Thanjavur. Seven strains were isolated from the external ocular infected samples and identified a standard manual of Determinative Bacteriology by Bergy’s manual 12th edition. The commercial antibiotics and eye drops tested against Bacillus cereus, B. subtilis, Escherichia coli, Klebsiella sp. Pseudomonas sp. Streptococcus sp. and Staphylococcus aureus. The majority of the isolates were sensitive to tobramycin followed by moxifloxacin, gatifloxacin and ofloxacin. The resistant antibiotics are ciprofloxin and sensitive antibiotic was ampicillin was recorded with respective bacteria.
Collapse
|
5
|
Agarwal N, McGregor B, Maughan B, Dorff T, Kelly W, Fang B, McKay R, Singh P, Pagliaro L, Dreicer R, Srinivas S, Loriot Y, Vaishampayan U, Goel S, Curran D, Panneerselvam A, Liu LF, Choueiri T, Pal S. LBA24 Cabozantinib (C) in combination with atezolizumab (A) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results of expanded cohort 6 of the COSMIC-021 study. Ann Oncol 2021. [DOI: 10.1016/j.annonc.2021.08.2100] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
6
|
Alaklabi A, Ahamed A, Al Qthanin RN, Arif IA, Panneerselvam A, Al-Khulaidi AW. Molecular characterization of endangered endemic plant Aloe pseudorubroviolacea using chloroplast matK and plastid rbcL gene. Saudi J Biol Sci 2021; 28:1123-1127. [PMID: 33424406 PMCID: PMC7783787 DOI: 10.1016/j.sjbs.2020.11.042] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2020] [Revised: 11/05/2020] [Accepted: 11/08/2020] [Indexed: 11/06/2022] Open
Abstract
An endangered and rare species Aloe pseudorubroviolacea from the plant family Asphodelaceae which is presently recorded as endangered in Saudi Arabia collected from Al-Baha region of Saudi Arabia its GPS Latitude and Longitude coordinates 19.8345, 41.5481. The chloroplast matK and rbcL gene was considered in this study based on molecular identification the size is about 571 and 664 bp respectively. From the sequence analysis the gene matK and rbcL confirm that this species is very much closely related with A. rubroviolacea and also inter related with the species Astroloba rubriflora, Chrysopogon gryllus, Chortolirion angolense shows about 98.7% sequence homology. The partial matK and rbcL gene sequence discriminate Aloe pseudorubroviolacea from the closely related plant species, A. rubroviolacea. The gene sequence of rbcL discriminates the species from Chrysopogon gryllus and Chortolirion angolense, demonstrates the nucleotide variations in 3 different sites (623C/T; 653C/T; 700C/A). This study showed that matK and rbcL sequence region of chloroplast gene used to authenticate the samples of A. pseudorubroviolacea and which provide to help in correct identification and conservation process of this medicinally valuable endangered plant species.
Collapse
Affiliation(s)
- Abdullah Alaklabi
- University of Jeddah, College of Science, Department of Biology, Jeddah, Saudi Arabia
| | - Anis Ahamed
- Prince Sultan Research Chair for Environment and Wildlife, Department of Botany and Microbiology, College of Sciences, King Saud University (KSU), Riyadh, Saudi Arabia
| | - Rahmah N Al Qthanin
- Biology Department, College of Sciences, King Khalid University, Abha, Saudi Arabia
| | - Ibrahim A Arif
- Prince Sultan Research Chair for Environment and Wildlife, Department of Botany and Microbiology, College of Sciences, King Saud University (KSU), Riyadh, Saudi Arabia
| | - A Panneerselvam
- Department of Botany and Microbiology, A.V.V.M. Sri Pushpam College (Autonomous) Poondi, Affiliated to Bharathidasan University, 620024, India
| | - Abdul Wali Al-Khulaidi
- Department of Biology, College of Science & Arts, Baljurashi, Albaha University, Saudi Arabia.,Agricultural research & Extension Authority, Yemen
| |
Collapse
|
7
|
Anis Ahamed N, Panneerselvam A, Arif IA, Syed Abuthakir MH, Jeyam M, Ambikapathy V, Mostafa AA. Identification of potential drug targets in human pathogen Bacillus cereus and insight for finding inhibitor through subtractive proteome and molecular docking studies. J Infect Public Health 2021; 14:160-168. [PMID: 33422858 DOI: 10.1016/j.jiph.2020.12.005] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2020] [Revised: 11/28/2020] [Accepted: 12/02/2020] [Indexed: 11/19/2022] Open
Abstract
Bacillus cereus is a gram-positive, anaerobic, spore-forming bacterium related to food poisoning in humans. Vomit and diarrhea are the symptoms of foodborne B. cereus infection caused by emetic toxins and three enterotoxins, respectively. This bacterium is broadly present in soil and foods such as vegetables, spices, milk, and meat. The antibiotics impenem, vancomycin, chloramphenicol, gentamicin, and ciprofloxacin are used for all susceptible strains of B. cereus. But these antibiotics cause side effects in the host due to the drug-host interaction; because the targeted proteins by the drugs are not pathogen specific proteins, they are similar to human proteins also. To overcome this problem, this study focused on identifying putative drug targets in the pathogen B. cereus and finding new drugs to inhibit the function of the pathogen. The identification of drug targets is a pipeline process, starting with the identification of targets non-homologous to human and gutmicrobiota proteins, finding essential proteins, finding other proteins that highly interact with these essential proteins that are also highly important for protein network stability, finding cytoplasmic proteins with a clear pathway and known molecular function, and finding non-druggable proteins. Through this process, two novel drug targets were identified in B. cereus. Among the various antibiotics, Gentamicin had showed good binding affinity with the identified novel targets through molecular modeling and docking studies using Prime and GLIDE module of Schrödinger. Hence, this study suggest that the identified novel drug targets may very useful in drug therapeutic field for finding inhibitors which are similar to Gentamicin and designing new formulation of drug molecules to control the function of the foodborne illness causing pathogen B. cereus.
Collapse
Affiliation(s)
- N Anis Ahamed
- Prince Sultan Research Chair for Environment and Wildlife, Department of Botany and Microbiology, College of Sciences, King Saud University (KSU), Riyadh, Saudi Arabia; Department of Botany and Microbiology, College of Sciences, King Saud University (KSU), Riyadh, Saudi Arabia; Department of Botany and Microbiology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Affiliated to Bharathidasan University, Thanjavur 620024, India.
| | - A Panneerselvam
- Department of Botany and Microbiology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Affiliated to Bharathidasan University, Thanjavur 620024, India
| | - Ibrahim A Arif
- Prince Sultan Research Chair for Environment and Wildlife, Department of Botany and Microbiology, College of Sciences, King Saud University (KSU), Riyadh, Saudi Arabia; Department of Botany and Microbiology, College of Sciences, King Saud University (KSU), Riyadh, Saudi Arabia
| | | | - Muthusamy Jeyam
- Biochematics Lab, Department of Bioinformatics, Bharathiar University, Coimbatore, India
| | - V Ambikapathy
- Department of Botany and Microbiology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Affiliated to Bharathidasan University, Thanjavur 620024, India
| | - Ashraf A Mostafa
- Department of Botany and Microbiology, College of Sciences, King Saud University (KSU), Riyadh, Saudi Arabia
| |
Collapse
|
8
|
Pal S, Tsao CK, Suarez C, Kelly W, Pagliaro L, Vaishampayan U, Loriot Y, Srinivas S, McGregor B, Panneerselvam A, Curran D, Choueiri T, Agarwal N. 702O Cabozantinib (C) in combination with atezolizumab (A) as first-line therapy for advanced clear cell renal cell carcinoma (ccRCC): Results from the COSMIC-021 study. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.08.774] [Citation(s) in RCA: 8] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
9
|
Ahamed A, Panneerselvam A, Alaklabi A, Arif IA, Ambikapathy V, Thajuddin N. Molecular perspective and anticancer activity of medicinal plants. Saudi J Biol Sci 2020; 27:666-675. [PMID: 32210686 PMCID: PMC6997859 DOI: 10.1016/j.sjbs.2019.11.043] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2019] [Revised: 11/28/2019] [Accepted: 11/28/2019] [Indexed: 11/21/2022] Open
Abstract
To evaluate phytochemical constituents from the methanolic extracts of medicinal plants Aloe castellorum and Aloe pseudorubroviolacea. The cytotoxic activity of Aloe castellorum and Aloe pseudorubroviolacea leaf extracts against Human colon cancer cell line (HCT-116) was also assessed. The two medicinal plant extracts having significant cytotoxic activity, meanwhile the methanolic extract of Aloe castellorum shows higher cytotoxic activity than Aloe pseudorubroviolacea extract. The Aloe castellorum shows remarkable activity against respective cell line than control. The characteristic chemical constituents of Aloe castellorum and Aloe pseudorubroviolacea leaf extracts were recognized from Gas chromatography and Mass spectrometry (GC–MS) technique. The molecular docking studies also support the cytotoxic activity.
Collapse
Affiliation(s)
- Anis Ahamed
- Prince Sultan Research Chair for Environment and Wildlife, Department of Botany and Microbiology, College of Sciences, King Saud University (KSU), Riyadh, Saudi Arabia
- Department of Botany and Microbiology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Affiliated to Bharathidasan University, Thanjavur, India
- Corresponding author.
| | - A. Panneerselvam
- Department of Botany and Microbiology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Affiliated to Bharathidasan University, Thanjavur, India
| | - Abdullah Alaklabi
- Faculty of Science, Department of Biological Science, University of Jeddah, Jeddah, Saudi Arabia
| | - Ibrahim A. Arif
- Prince Sultan Research Chair for Environment and Wildlife, Department of Botany and Microbiology, College of Sciences, King Saud University (KSU), Riyadh, Saudi Arabia
| | - V. Ambikapathy
- Department of Botany and Microbiology, A.V.V.M. Sri Pushpam College (Autonomous), Poondi, Affiliated to Bharathidasan University, Thanjavur, India
| | - N. Thajuddin
- Department of Microbiology, Bharathidasan University, Tiruchirappalli, India
| |
Collapse
|
10
|
Punitha S, Uvarani R, Panneerselvam A, Nithiyanantham S. Physico-chemical studies on binary aqueous solutions of Anti-Viral Influenza drugs. Heliyon 2019; 5:e01941. [PMID: 31249897 PMCID: PMC6584764 DOI: 10.1016/j.heliyon.2019.e01941] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/31/2018] [Revised: 05/13/2019] [Accepted: 06/06/2019] [Indexed: 11/19/2022] Open
Abstract
The ultrasonic velocity, density, viscosity and absorption have been measured for solution of Influenza Anti-Viral drugs (Amantadine and Oseltamivir) are presented at room temperature 303K. By taking measurements of Anti Influenza Viral drugs at 0.2, 0.4 and 0.6% concentrations of each solution. The aim of the study is to increase the solubility, stability, sweetness of drugs by the formation of complexation. The ultrasonic velocity, density and viscosity have been measured at 2MHz for the aqueous solutions of (i) Influenza Anti-Viral Drugs + HPMC (Hydroxy Propyl Methyl Cellulose), Lactose and CaCl2 (Calcium Chloride at different concentrations at a temperature 303K.The acoustical parameters such as adiabatic compressibility (β), intermolecular free length (Lf), internal pressure (πi), Rao's constant (R), relaxation time (τ), acoustical impedance (Za), absorption coefficient (α/f2), free volume (Vf), cohesive energy and solvation number (Sn) have been computed. These properties are attributed to solute-solvent interactions through hydrogen bonding, segment-segment interaction, molecular association, polymer-solvent interaction, polymer-polymer interaction and etc. The total absorption can be considered as the sum of contributions from solute-solvent interactions. These results are further supported by FTIR studies.
Collapse
Affiliation(s)
- S Punitha
- Department of Physics, Pavai Arts and Science College, Namakkal,Tamilnadu, 637018, India
| | - R Uvarani
- Department of Physics, Thiruvalluvar Govt. Arts College, Tamilnadu, Namakkal, 637401, India
| | - A Panneerselvam
- Department of Physics, Pavai Engineering College, Tamilnadu, Namakkal, 637018, India
| | - S Nithiyanantham
- Department of Physics, Thiru.Vi. Kalyanasundaram Govt Arts and Science College, 610003, Thiruvaur, Tamilnadu, India
| |
Collapse
|
11
|
Kalpana V, Kataru BAS, Sravani N, Vigneshwari T, Panneerselvam A, Devi Rajeswari V. Biosynthesis of zinc oxide nanoparticles using culture filtrates of Aspergillus niger: Antimicrobial textiles and dye degradation studies. OpenNano 2018. [DOI: 10.1016/j.onano.2018.06.001] [Citation(s) in RCA: 36] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
|
12
|
Kalpana Devi R, Vasantha S, Panneerselvam A, Rajesh NV, Jeyathilakan N, Venkataramanan R. Gastrothylax crumenifer: ultrastructure and histopathology study of in vitro trematodicidal effect of Microlepia speluncae (L.) Moore. Journal of Applied Animal Research 2018. [DOI: 10.1080/09712119.2017.1331849] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
- R. Kalpana Devi
- PG and Research Department of Botany and Microbiology, A.V.V.M Sri Pushpam College (Autonomous), Bharathidasan University (Affiliated), Thanjavur, Tamil Nadu, India
| | - S. Vasantha
- PG and Research Department of Botany and Microbiology, A.V.V.M Sri Pushpam College (Autonomous), Bharathidasan University (Affiliated), Thanjavur, Tamil Nadu, India
| | - A. Panneerselvam
- PG and Research Department of Botany and Microbiology, A.V.V.M Sri Pushpam College (Autonomous), Bharathidasan University (Affiliated), Thanjavur, Tamil Nadu, India
| | - N. V. Rajesh
- Veterinary University Training and Research Centre, Tamilnadu Veterinary and Animal Sciences University, Ramanathapuram, Tamil Nadu, India
| | - N. Jeyathilakan
- Department of Veterinary Parasitology, Veterinary College and Research Institute, Tamilnadu Veterinary and Animal Sciences University, Thanjavur, Tamil Nadu, India
| | - R. Venkataramanan
- Post Graduate Research Institute in Animal Sciences, Tamilnadu Veterinary and Animal Sciences University, Kancheepuram 603 203, Tamil Nadu, India
| |
Collapse
|
13
|
Sangeetha M, Kanimozhi K, Panneerselvam A, Kumar RS. Biodegradation of Pesticide using Fungi Isolated from Paddy Fields of Thanjavur District, India. ACTA ACUST UNITED AC 2016. [DOI: 10.20546/ijcmas.2016.510.039] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
14
|
Abstract
Teneligliptin is a recently developed oral dipeptidyl peptidase 4 inhibitor indicated for the management of type 2 diabetes mellitus (T2DM) in adults along with diet and exercise. Teneligliptin has been recently available in Japan (Teneria(®)), Argentina (Teneglucon(®)), and India (Tenepure; Teneza) at relatively affordable price. This is a positive step toward the management of T2DM in developing countries, where the cost of medicine is out-of-pocket expenditure and is a limiting factor for health care. This review evaluates the efficacy and safety of teneligliptin in the management of T2DM. Teneligliptin has been systematically evaluated in T2DM as monotherapy with diet and exercise and in combination with metformin, glimepiride, pioglitazone, and insulin in short-term (12 weeks) and long-term (52 weeks) studies. These studies have reported a reduction in HbA1c of 0.8%-0.9% within 12 weeks of therapy. Two 52-week studies reported sustained improvement in glycemic control with teneligliptin. Teneligliptin has been found to be well tolerated, and the safety profile is similar to other dipeptidyl peptidase 4 inhibitors. Hypoglycemia and constipation are the main adverse events. Teneligliptin can be administered safely to patients with mild, moderate, or severe renal impairment or end-stage renal disease without dose adjustment. Similarly, it can be used in patients with mild-to-moderate hepatic impairment. Teneligliptin is effective and well tolerated and may have an important role in the management of T2DM.
Collapse
Affiliation(s)
| | | | - KP Singh
- Fortis Hospital, Sector 62, Phase VIII, Mohali
| | - Girish Parmar
- Kokilaben Dhirubhai Ambani Hospital, Andheri (W), Mumbai
| | | | - Onkar C Swami
- Unichem Laboratories Ltd, Jogeshwari (W), Mumbai, India
| |
Collapse
|
15
|
Chandraleka S, Ramya K, Chandramohan G, Dhanasekaran D, Priyadharshini A, Panneerselvam A. Antimicrobial mechanism of copper (II) 1,10-phenanthroline and 2,2′-bipyridyl complex on bacterial and fungal pathogens. Journal of Saudi Chemical Society 2014. [DOI: 10.1016/j.jscs.2011.11.020] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
16
|
Punitha S, Uvarani R, Panneerselvam A, Nithiyanantham S. Physico-chemical studies on some saccharides in aqueous cellulose solutions at different temperatures – Acoustical and FTIR analysis. Journal of Saudi Chemical Society 2014. [DOI: 10.1016/j.jscs.2014.01.008] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
17
|
Stürzenbaum SR, Höckner M, Panneerselvam A, Levitt J, Bouillard JS, Taniguchi S, Dailey LA, Ahmad Khanbeigi R, Rosca EV, Thanou M, Suhling K, Zayats AV, Green M. Biosynthesis of luminescent quantum dots in an earthworm. Nat Nanotechnol 2013; 8:57-60. [PMID: 23263722 DOI: 10.1038/nnano.2012.232] [Citation(s) in RCA: 90] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/24/2012] [Accepted: 11/16/2012] [Indexed: 05/26/2023]
Abstract
The synthesis of designer solid-state materials by living organisms is an emerging field in bio-nanotechnology. Key examples include the use of engineered viruses as templates for cobalt oxide (Co(3)O(4)) particles, superparamagnetic cobalt-platinum alloy nanowires and gold-cobalt oxide nanowires for photovoltaic and battery-related applications. Here, we show that the earthworm's metal detoxification pathway can be exploited to produce luminescent, water-soluble semiconductor cadmium telluride (CdTe) quantum dots that emit in the green region of the visible spectrum when excited in the ultraviolet region. Standard wild-type Lumbricus rubellus earthworms were exposed to soil spiked with CdCl(2) and Na(2)TeO(3) salts for 11 days. Luminescent quantum dots were isolated from chloragogenous tissues surrounding the gut of the worm, and were successfully used in live-cell imaging. The addition of polyethylene glycol on the surface of the quantum dots allowed for non-targeted, fluid-phase uptake by macrophage cells.
Collapse
Affiliation(s)
- S R Stürzenbaum
- Analytical and Environmental Sciences Division, King's College London, London SE1 9NH, UK
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Yao J, Shah M, Panneerselvam A, Stergiopoulos S, Chen D, Ito T, Pavel M. The Vegf Pathway in Patients with Pancreatic Neuroendocrine Tumors: Efficacy of Everolimus by Baseline Marker Level, and Prognostic and Predictive Effect Analyses from Radiant-3. Ann Oncol 2012. [DOI: 10.1093/annonc/mds405] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
19
|
Oudard S, Escudier B, Thompson J, Grünwald V, Conte P, Bracarda S, Panneerselvam A, Gogov S, Chen D, Motzer R. Biomarkers of Everolimus Efficacy in Patients with Metastatic Renal Cell Carcinoma (MRCC): Analysis of the Phase III Record-1 Trial. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)33413-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
20
|
Gnant M, Noguchi S, Ito Y, Piccart M, Baselga J, Panneerselvam A, Taran T, Sahmoud T, Hortobagyi G, Pritchard K. Safety of Everolimus For Women Over 65 Years of Age With Advanced Breast Cancer: 18-Mo Follow-Up of BOLERO-2. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)32913-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
21
|
Campone M, Noguchi S, Pritchard K, Rugo H, Hortobagyi G, Baselga J, Panneerselvam A, Taran T, Sahmoud T, Piccart M. Efficacy and Safety of Everolimus in Postmenopausal Women With Advanced Breast Cancer (BOLERO-2): Effect of Visceral Metastases and Prior Endocrine Therapy. Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)32953-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
22
|
Panneerselvam A, T T S P, Subbiahnadar P. New onset dyspnoea at 82 years. Case Reports 2012; 2012:bcr.03.2012.5978. [DOI: 10.1136/bcr.03.2012.5978] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
23
|
Bracarda S, Hutson TE, Porta C, Figlin RA, Calvo E, Grünwald V, Ravaud A, Motzer R, Kim D, Anak O, Panneerselvam A, Escudier B. Everolimus in metastatic renal cell carcinoma patients intolerant to previous VEGFr-TKI therapy: a RECORD-1 subgroup analysis. Br J Cancer 2012; 106:1475-80. [PMID: 22441644 PMCID: PMC3341863 DOI: 10.1038/bjc.2012.89] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2011] [Revised: 02/17/2012] [Accepted: 02/22/2012] [Indexed: 11/09/2022] Open
Abstract
BACKGROUND A relevant percentage of patients with metastatic renal cell carcinoma develop intolerance to vascular endothelial growth factor receptor-tyrosine kinase inhibitors (VEGFr-TKIs) and require careful selection of subsequent treatment. This retrospective analysis evaluated the safety and efficacy of everolimus in patients enrolled in the phase-III RECORD-1 trial who discontinued previous VEGFr-TKI therapy because of toxicity. METHODS Patients with an adverse event (AE) as their primary reason for discontinuation of previous VEGFr-TKI therapy were included. Median progression-free survival (PFS) for VEGFr-TKI-intolerant patients in each arm was estimated using the Kaplan-Meier method, and effect on PFS (hazard ratio (HR)) was calculated using the Cox proportional hazard model. RESULTS In VEGFr-TKI-intolerant patients (n=58, 14%), median PFS was 5.4 months with everolimus and 1.9 months with placebo (HR: 0.32; P=0.004). In sunitinib-intolerant patients (n=26), median PFS was 5.1 months with everolimus and 2.8 months with placebo (HR: 0.28; P=0.033). Grade 3/4 AEs reported with everolimus in VEGFr-TKI-intolerant patients included infections (16%), fatigue (7%) and stomatitis (4%). The toxicity profile of everolimus was similar in the VEGFr-TKI-intolerant and overall study populations. CONCLUSION Everolimus is well tolerated and efficacious with no increased toxicity in patients intolerant to VEGFr-TKI therapy.
Collapse
Affiliation(s)
- S Bracarda
- Ospedale San Donato USL8, Istituto Toscano Tumori, Arezzo, Italy.
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Fu P, Panneerselvam A, Clifford B, Dowlati A, Ma PC, Zeng G, Halmos B, Leidner RS. Simpson's paradox - aggregating and partitioning populations in health disparities of lung cancer patients. Stat Methods Med Res 2012; 24:937-48. [PMID: 22246415 DOI: 10.1177/0962280211434179] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
It is well known that non-small cell lung cancer (NSCLC) is a heterogeneous group of diseases. Previous studies have demonstrated genetic variation among different ethnic groups in the epidermal growth factor receptor (EGFR) in NSCLC. Research by our group and others has recently shown a lower frequency of EGFR mutations in African Americans with NSCLC, as compared to their White counterparts. In this study, we use our original study data of EGFR pathway genetics in African American NSCLC as an example to illustrate that univariate analyses based on aggregation versus partition of data leads to contradictory results, in order to emphasize the importance of controlling statistical confounding. We further investigate analytic approaches in logistic regression for data with separation, as is the case in our example data set, and apply appropriate methods to identify predictors of EGFR mutation. Our simulation shows that with separated or nearly separated data, penalized maximum likelihood (PML) produces estimates with smallest bias and approximately maintains the nominal value with statistical power equal to or better than that from maximum likelihood and exact conditional likelihood methods. Application of the PML method in our example data set shows that race and EGFR-FISH are independently significant predictors of EGFR mutation.
Collapse
Affiliation(s)
- P Fu
- Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
| | - A Panneerselvam
- Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA
| | - B Clifford
- Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA
| | - A Dowlati
- Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA
| | - P C Ma
- Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA
| | - G Zeng
- College of Education, Texas A &M University - Corpus Christi, Corpus Christi, TX, USA
| | - B Halmos
- Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, USA
| | - R S Leidner
- Seidman Cancer Center, Case Western Reserve University School of Medicine, Cleveland, OH, USA
| |
Collapse
|
25
|
Calvo E, Escudier B, Motzer RJ, Oudard S, Hutson TE, Porta C, Bracarda S, Grünwald V, Thompson JA, Ravaud A, Kim D, Panneerselvam A, Anak O, Figlin RA. Everolimus in metastatic renal cell carcinoma: Subgroup analysis of patients with 1 or 2 previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor therapies enrolled in the phase III RECORD-1 study. Eur J Cancer 2011; 48:333-9. [PMID: 22209391 DOI: 10.1016/j.ejca.2011.11.027] [Citation(s) in RCA: 89] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2011] [Revised: 11/22/2011] [Accepted: 11/25/2011] [Indexed: 12/16/2022]
Abstract
INTRODUCTION In the phase III RECORD-1 trial (ClinicalTrials.gov: NCT00410124), patients with metastatic renal cell carcinoma (mRCC) who progressed on previous vascular endothelial growth factor receptor-tyrosine kinase inhibitor (VEGFr-TKI) therapy were randomised 2:1 to everolimus 10mg once daily (n=277) or placebo (n=139). Median progression-free survival (PFS) was 4.9months with everolimus and 1.9months with placebo (hazard ratio [HR], 0.33; P<.001). This preplanned, prospective sub-analysis evaluated PFS benefit of everolimus versus placebo in patients who had previously received 1 or 2 VEGFr-TKIs. PATIENTS AND METHODS Median PFS was estimated using the Kaplan-Meier method, and Cox proportional hazards model was used to analyse differences in PFS. RESULTS All patients (100%) received ⩾1 previous VEGFr-TKI; 26% of patients received 2 previous VEGFr-TKIs. Among patients who received 1 previous VEGFr-TKI, median PFS was 5.4months with everolimus and 1.9months with placebo (HR, 0.32; 95%confidence interval [CI], 0.24-0.43; P<.001). Among patients who received 2 previous VEGFr-TKIs, median PFS was 4.0months with everolimus and 1.8months with placebo (HR, 0.32; 95%CI, 0.19-0.54; P<.001). The everolimus safety profile was similar for both groups. CONCLUSIONS Everolimus was associated with prolonged PFS relative to placebo in patients who received 1 or 2 previous VEGFr-TKIs. Patients who received only 1 previous VEGFr-TKI had apparently longer PFS with everolimus in reference to those who received 2 previous VEGFr-TKIs. These results support the use of everolimus as the standard of care in patients who fail initial VEGFr-TKI therapy.
Collapse
Affiliation(s)
- E Calvo
- START Madrid, Centro Integral Oncológico Clara Campal, Hospital Madrid Norte Sanchinarro, Madrid, Spain.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
26
|
Panneerselvam A, Krishnamurthy AH, Bhat P, Nanjappa MC. Delayed contrast enhancement in MRI in takotsubo cardiomyopathy. Case Reports 2011; 2011:bcr.06.2011.4324. [DOI: 10.1136/bcr.06.2011.4324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
27
|
Yao J, Tsuchihashi Z, Panneerselvam A, Winkler R, Bugarini R, Pavel M. 6573 POSTER Effect of Everolimus Treatment on Markers of Angiogenesis in Patients With Advanced Pancreatic Neuroendocrine Tumours (pNET) – Results From the Phase III RADIANT-3 Study. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)71884-6] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
28
|
Larkin J, Blank C, Bono P, Kim D, Panneerselvam A, Grünwald V. 7147 POSTER The REACT Expanded-access Program of Everolimus in Patients With Metastatic Renal Cell Carcinoma Refractory to VEGF-targeted Therapy: Subgroup Analyses by Prior Therapy. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)72062-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
29
|
Fazio N, Granberg D, Grossman A, Saletan S, Winkler R, Panneerselvam A, Wolin E. 6572 POSTER Effect of Everolimus + Octreotide LAR in Patients With Advanced Lung Neuroendocrine Tumours – Analysis From RADIANT-2. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)71883-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
30
|
Bono P, Kim D, Panneerselvam A, Grünwald V. 7148 POSTER Hyperglycemia and Hypercholesterolemia and Associated Outcomes of Patients With Metastatic Renal Cell Carcinoma Treated With Everolimus in the Expanded-access Program REACT. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)72063-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
31
|
Pommier RF, Wolin EM, Panneerselvam A, Saletan S, Winkler RE, Van Cutsem E. Impact of prior chemotherapy on progression-free survival in patients (pts) with advanced pancreatic neuroendocrine tumors (pNET): Results from the RADIANT-3 trial. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.4103] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
32
|
Ruszniewski P, Tomassetti P, Saletan S, Panneerselvam A, Yao JC. Everolimus plus octreotide LAR versus placebo plus octreotide LAR in patients (pts) with advanced neuroendocrine tumors: Multivariate analysis of progression-free survival from the RADIANT-2 trial. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e21084] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
33
|
Porta C, Escudier B, Hutson TE, Figlin RA, Calvo E, Grünwald V, Osanto S, Ravaud A, Panneerselvam A, Knox JJ, Motzer RJ. Analysis of the relationship between Karnofsky performance status (KPS) and tumor response in the RECORD-1 phase III trial of everolimus in patients with advanced renal cell carcinoma (RCC). J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.4610] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
34
|
Wolin EM, Fazio N, Saletan S, Winkler RE, Panneerselvam A, Kvols L. Everolimus plus octreotide LAR versus placebo plus octreotide LAR in patients with advanced neuroendocrine tumors: Analysis by primary tumor site from RADIANT-2. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.4075] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
35
|
Hobday TJ, Capdevila J, Saletan S, Panneerselvam A, Pommier RF. Everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET): Multivariate analysis of progression-free survival from the RADIANT-3 trial. J Clin Oncol 2011. [DOI: 10.1200/jco.2011.29.15_suppl.e21091] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
36
|
Vijayakumar R, Panneerselvam K, Muthukumar C, Thajuddin N, Panneerselvam A, Saravanamuthu R. Optimization of Antimicrobial Production by a Marine Actinomycete Streptomyces afghaniensis VPTS3-1 Isolated from Palk Strait, East Coast of India. Indian J Microbiol 2011; 52:230-9. [PMID: 23729887 DOI: 10.1007/s12088-011-0138-x] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2009] [Accepted: 04/30/2010] [Indexed: 11/29/2022] Open
Abstract
Totally 25 marine soil samples were collected from the region of Palk Strait of Bay of Bengal, Tamil Nadu, and were subjected to the isolation of actinomycetes. Sixty-eight morphologically distinct isolates were obtained and 37% (25) of them had antimicrobial activity. The potential producer was named as Streptomyces sp. VPTS3-1 and the phylogenetic evaluation on the basis of 16S rDNA sequence further categorized the organism as Streptomyces afghaniensis VPTS3-1. Further, the antimicrobial compound was extracted from the isolate using various solvents and the antimicrobial efficacies were tested against bacterial and fungal pathogens. In addition, in vitro optimization of parameters for the antimicrobial compound production revealed that the suitable pH as 7-8, the period of incubation as 9 days, temperature (30°C), salinity (2%), and starch and KNO3 as the suitable carbon and nitrogen sources respectively in starch-casein medium.
Collapse
Affiliation(s)
- R Vijayakumar
- Department of Microbiology, Bharathidasan University College (W), Orathanadu, 614 625 India
| | | | | | | | | | | |
Collapse
|
37
|
Dhanasekaran D, Latha S, Saha S, Thajuddin N, Panneerselvam A. Biosynthesis and Antimicrobial Potential of Metal Nanoparticles. ACTA ACUST UNITED AC 2011. [DOI: 10.1080/19430892.2011.574545] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
38
|
Friedman L, Abdallah R, Schluchter M, Panneerselvam A, Kunos C. Adherence to Vaginal Dilation following High Dose Rate Brachytherapy for Endometrial Cancer. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.1191] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
39
|
Galanopoulos N, Silverman P, Panneerselvam A, Leeming R, Shenk R, Persons M, Kim E, Spencer B, Lyons J. Impact of Isolated Tumor Cells and Micrometastases in SLNs: Local Management and Recurrence Risk. Int J Radiat Oncol Biol Phys 2009. [DOI: 10.1016/j.ijrobp.2009.07.141] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
40
|
Ortiz P, Bissada NF, Palomo L, Han YW, Al-Zahrani MS, Panneerselvam A, Askari A. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol 2009; 80:535-40. [PMID: 19335072 DOI: 10.1902/jop.2009.080447] [Citation(s) in RCA: 219] [Impact Index Per Article: 14.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
BACKGROUND Rheumatoid arthritis (RA) and periodontitis are common chronic inflammatory conditions. Recent studies showed a beneficial effect of periodontal treatment on the severity of active RA. This study was undertaken to further examine the effect of non-surgical periodontal treatment on the signs and symptoms of RA in patients treated with or without anti-tumor necrosis factor-alpha (anti-TNF-alpha) medications. The effect of anti-TNF-alpha therapy on periodontitis also was assessed. METHODS Forty participants diagnosed with moderate/severe RA (under treatment for RA) and severe periodontitis were randomly assigned to receive initial non-surgical periodontal therapy with scaling/root planing and oral hygiene instructions (n = 20) or no periodontal therapy (n = 20). To control RA, all participants had been using disease-modifying anti-rheumatic drugs, and 20 had also been using anti-TNF-alpha before randomization. Probing depth (PD), clinical attachment level (CAL), bleeding on probing (BOP), gingival index (GI), plaque index (PI), RA disease activity score 28 (DAS28), and erythrocyte sedimentation rate (ESR) were measured at baseline and 6 weeks later. Linear mixed models were used to identify significant differences between subjects who received periodontal treatment and those who did not. RESULTS Patients receiving periodontal treatment showed a significant decrease in the mean DAS28, ESR (P <0.001), and serum TNF-alpha (P <0.05). There was no statistically significant decrease in these parameters in patients not receiving periodontal treatment. Anti-TNF-alpha therapy resulted in a significant improvement in CAL, PD, BOP, and GI. CONCLUSIONS Non-surgical periodontal therapy had a beneficial effect on the signs and symptoms of RA, regardless of the medications used to treat this condition. Anti-TNF-alpha therapy without periodontal treatment had no significant effect on the periodontal condition.
Collapse
Affiliation(s)
- P Ortiz
- Department of Periodontics, Case Western Reserve University, Cleveland, OH 44106-4905, USA
| | | | | | | | | | | | | |
Collapse
|
41
|
Averbook BJ, Jukic D, Rao JS, Panneerselvam A, Delman K, Zager JS, Sabel M, Pittelkow MR, Swetter S, Kirkwood JM. First analysis of an international pediatric melanoma and atypical melanocytic neoplasm database. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.9013] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
9013 Background: Pediatric melanoma (PM) care has been extrapolated from adult melanoma data. PM and atypical melanocytic neoplasms (AMNs) appear to have different biology. An international database (DB) was developed to clarify their behavior. Methods: IRB approval was obtained at 12 institutions. An SQL-DB was developed for web entry of de-identified demographic and pathologic data for PM and AMN patients (pts) < 21yr through an honest broker system at the University of Pittsburgh. Institutions retained a key of pts entered with assigned numbers for quality assurance and updates. Statistical analysis used Kaplan-Meier survival curves, univariate linear trends and log rank tests. In situ melanoma was excluded from PM survival analysis. Results: 828 pts were registered as of 31 Oct 2008 (ages 11mo-23; median 15yr). 34 pts 21–23yr entered were left in the DB for statistical comparison. Diagnosis years ranged from 1936–2008. 455 pts had complete follow-up. Too few AMN pts had complete follow-up for analysis (18/208). After excluding 32 in situ and 40 with other incomplete data, 365 PM out of 415 total PM were evaluable for OS and 351 for DFS (Stage IV removed). Mean/median age for evaluable PM pts was 16.44/17-yrs (range 1–21yr). 591 pts were age 10–20 while 203 were < 10. Sentinel lymph node (SLN) biopsy showed spread in 30.1 % PM pts (compared to 50% [4/8] of AMN SLN pts). 10-yr PM OS was 80.6%, and pts 0–10 yr had 100% 10-yr OS compared to 69.6% for pts age 10–15 and 79.49% for age 15–20 (p= 0.1473). OS did not differ significantly by gender. Stage predicted OS (p<0.0001). 10-yr OS was 94.13% for Stage I (n=174), 79.62% for stage II (n=67) & 77.14% for stage III (n=75). Thickness affected 10-yr OS: 0–1mm=97% (n=147), 1.1–2mm 70% (n=84), 2.01–4mm 78% (n=71) & >4mm 81% (n=25), p= 0.0099. Survival was similar for pts with PM > 1mm of the several T stage groupings. Ulceration adversely affected OS (p=0.022). Mitosis, defined as present/absent did not alter survival. Nodal metastasis correlated with worse OS (p= 0.170). Conclusions: Stage, thickness, ulceration, and nodal status are significant predictors of OS for PM. Further study will focus on multivariable analysis of PM and AMNs after updating pts, increasing accrual, and cleaning data. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- B. J. Averbook
- Metrohealth Medical Center/CWRU, Cleveland, OH; University of Pittsburgh, Pittsburgh, PA; Case Western Reserve University, Cleveland, OH; Emory University, Atlanta, GA; H. Lee Moffitt Cancer Center, Tampa, FL; University of Michigan, Ann Arbor, MI; Mayo Clinic, Rochester, MN; Stanford University/VA Palo Alto, Stanford, CA
| | - D. Jukic
- Metrohealth Medical Center/CWRU, Cleveland, OH; University of Pittsburgh, Pittsburgh, PA; Case Western Reserve University, Cleveland, OH; Emory University, Atlanta, GA; H. Lee Moffitt Cancer Center, Tampa, FL; University of Michigan, Ann Arbor, MI; Mayo Clinic, Rochester, MN; Stanford University/VA Palo Alto, Stanford, CA
| | - J. S. Rao
- Metrohealth Medical Center/CWRU, Cleveland, OH; University of Pittsburgh, Pittsburgh, PA; Case Western Reserve University, Cleveland, OH; Emory University, Atlanta, GA; H. Lee Moffitt Cancer Center, Tampa, FL; University of Michigan, Ann Arbor, MI; Mayo Clinic, Rochester, MN; Stanford University/VA Palo Alto, Stanford, CA
| | - A. Panneerselvam
- Metrohealth Medical Center/CWRU, Cleveland, OH; University of Pittsburgh, Pittsburgh, PA; Case Western Reserve University, Cleveland, OH; Emory University, Atlanta, GA; H. Lee Moffitt Cancer Center, Tampa, FL; University of Michigan, Ann Arbor, MI; Mayo Clinic, Rochester, MN; Stanford University/VA Palo Alto, Stanford, CA
| | - K. Delman
- Metrohealth Medical Center/CWRU, Cleveland, OH; University of Pittsburgh, Pittsburgh, PA; Case Western Reserve University, Cleveland, OH; Emory University, Atlanta, GA; H. Lee Moffitt Cancer Center, Tampa, FL; University of Michigan, Ann Arbor, MI; Mayo Clinic, Rochester, MN; Stanford University/VA Palo Alto, Stanford, CA
| | - J. S. Zager
- Metrohealth Medical Center/CWRU, Cleveland, OH; University of Pittsburgh, Pittsburgh, PA; Case Western Reserve University, Cleveland, OH; Emory University, Atlanta, GA; H. Lee Moffitt Cancer Center, Tampa, FL; University of Michigan, Ann Arbor, MI; Mayo Clinic, Rochester, MN; Stanford University/VA Palo Alto, Stanford, CA
| | - M. Sabel
- Metrohealth Medical Center/CWRU, Cleveland, OH; University of Pittsburgh, Pittsburgh, PA; Case Western Reserve University, Cleveland, OH; Emory University, Atlanta, GA; H. Lee Moffitt Cancer Center, Tampa, FL; University of Michigan, Ann Arbor, MI; Mayo Clinic, Rochester, MN; Stanford University/VA Palo Alto, Stanford, CA
| | - M. R. Pittelkow
- Metrohealth Medical Center/CWRU, Cleveland, OH; University of Pittsburgh, Pittsburgh, PA; Case Western Reserve University, Cleveland, OH; Emory University, Atlanta, GA; H. Lee Moffitt Cancer Center, Tampa, FL; University of Michigan, Ann Arbor, MI; Mayo Clinic, Rochester, MN; Stanford University/VA Palo Alto, Stanford, CA
| | - S. Swetter
- Metrohealth Medical Center/CWRU, Cleveland, OH; University of Pittsburgh, Pittsburgh, PA; Case Western Reserve University, Cleveland, OH; Emory University, Atlanta, GA; H. Lee Moffitt Cancer Center, Tampa, FL; University of Michigan, Ann Arbor, MI; Mayo Clinic, Rochester, MN; Stanford University/VA Palo Alto, Stanford, CA
| | - J. M. Kirkwood
- Metrohealth Medical Center/CWRU, Cleveland, OH; University of Pittsburgh, Pittsburgh, PA; Case Western Reserve University, Cleveland, OH; Emory University, Atlanta, GA; H. Lee Moffitt Cancer Center, Tampa, FL; University of Michigan, Ann Arbor, MI; Mayo Clinic, Rochester, MN; Stanford University/VA Palo Alto, Stanford, CA
| |
Collapse
|
42
|
Seshiah V, Balaji V, Balaji MS, Panneerselvam A, Thamizharasi M, Arthi T. Glycemic level at the first visit and prediction of GDM. J Assoc Physicians India 2007; 55:630-632. [PMID: 18051734] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/25/2023]
Abstract
OBJECTIVE To evaluate the glycemic level at the first visit that is likely to predict gestational diabetes mellitus (GDM). METHODS Consecutive pregnant women underwent a 75g oral glucose tolerance Test (OGTT) recommended by WHO and diagnosed GDM if 2hr post plasma glucose (PG) value > or = 140 mg/dl. Women with normal OGTT results at the first visit were screened again with an OGTT at the subsequent visits. RESULTS A total of 4151 pregnant women from different trimesters underwent OGTT. Of them 739 women (17.8%) had GDM. Among the GDM women, 528 (71.4%) were detected at the first visit. On screening during subsequent visits, GDM was diagnosed in the remaining 211(28.6%) women who had normal OGTT in the first visit. We performed the analysis taking the glycemic level in the first visit of 211 pregnant women who manifested GDM in the subsequent visit. During normal pregnancy, 2hr PG level is < 120 mg/dl. Taking this value into consideration among the 211 women who turned to have GDM in the subsequent visits 119 women (56.4%) had 2hrPG > or = 120 mg/dl and the remaining 92(43.6%) had 2hrPG < 120 mg/dl. CONCLUSION Pregnant women irrespective of 2 hr PG > or = or < 120 mg/dl at initial visit progressed to GDM in the subsequent visit. No glycemic level in the early weeks of pregnancy predicts GDM and at the same time at no statistically significant glycemic cut-off level could we say that a woman will not develop GDM. Hence rescreening in the subsequent trimester or visits is essential.
Collapse
|
43
|
Abstract
The use of a peripherally inserted central catheter (PICC) is occasionally complicated by intravascular fracture and central embolization of the catheter fragment. We present a patient in whom a PICC fragment was retrieved from the pulmonary artery 11 years after embolization following its incidental detection. Despite a history of IV drug abuse and mitral regurgitation, this patient remained asymptomatic and without complications. The catheter fragment was retrieved since the patient was believed to be at risk for endocarditis. This may be the longest duration reported of an embolized catheter fragment that was successfully removed. As the natural history of asymptomatic-retained central venous foreign bodies remains unclear, the decision to remove them should be individualized. In selected cases, these foreign bodies may be retrieved without complications even several years after embolization.
Collapse
Affiliation(s)
- S Thanigaraj
- Cardiovascular Division, Washington University, St. Louis, MO 63110, USA.
| | | | | |
Collapse
|